Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
This study has been completed.
Study NCT00057759 Information provided by National Cancer Institute (NCI)
First Received: April 7, 2003 Last Updated: July 20, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Radiation Toxicity
Sexual Dysfunction and Infertility
Sexuality and Reproductive Issues
Additional conditions recognized in this trial
Erectile Dysfunction
Infertility
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Female
Genital Diseases, Male
Genital Neoplasms, Male
Mental Disorders
Neoplasms
Neoplasms by Site
Prostatic Diseases
Sexual and Gender Disorders
Sexual Dysfunction, Physiological
Sexual Dysfunctions, Psychological
Urogenital Neoplasms
Interventions listed in this trial
sildenafil citrate
Additional drug interventions recognized in this trial
Sildenafil
More general drug interventions related to this trial
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
Back to top of Main Content
